| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/24/2005 | US20050043357 Mitotic kinesin inhibitors |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043334 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 02/24/2005 | US20050043331 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043326 Compounds |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043310 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043295 Pharmaceutically effective compounds |
| 02/24/2005 | US20050043292 eg S)-[5-amino-6-oxo-6-(3,3,4,4-tetrafluoro-pyrrolidin-1-yl)-hexyl-carbamic acid benzylester; Type 2 diabetes, metabolic syndrome (syndrome X or insulin resistance syndrome), hyperglycemia, impaired glucose tolerance, glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy |
| 02/24/2005 | US20050043290 for treating neurodegenerative disease such as Alzheimer's disease |
| 02/24/2005 | DE102004010545A1 Pyrazoline Pyrazolines |
| 02/24/2005 | CA2536470A1 Pyrrole compositions useful as inhibitors of c-met |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | CA2534047A1 Oxazoles derivatives, their manufacture and their use as tyrosine kinase inhibitors |
| 02/24/2005 | CA2518774A1 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507764A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 02/23/2005 | EP1507762A1 Pesticidal pyridinecarboxamide derivatives |
| 02/23/2005 | EP1507761A1 Pyridine carboxamide derivatives and their use as pesticides |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507549A2 Drug therapy for celiac sprue |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1395583B1 New phenylpiperazines |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585643A Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1585152A Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance |
| 02/23/2005 | CN1190434C Novel heterocyclic compounds and process for its preparation, and pharmaceutical compositions containing them and their use in treatment of diabetes and related diseases |
| 02/23/2005 | CN1190433C Phenylpiperazine |
| 02/23/2005 | CN1190432C Piperazing derivatives as 5-HTIB antagonists |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190423C Heteroycle derivatives and drugs |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858635 Photoreceptive detectors such as 2-(4-(4-((5S)-5-((Acetylamino )methyl)-2-oxo-3-oxazolidinyl)-2-fluorophenyl)-1-piperazinyl)-2-oxoethyl-4 -azido-2-hydroxy-5-iodobenzoate, used for analyzing binding in grampositive and negative bacteria |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858623 Amidino and guanidino peptidyl compounds |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014578A1 Phenylsulfonyl compounds as antipsychotic agents |
| 02/17/2005 | WO2005014571A1 Substituted piperidines as histamine h3 receptor ligands |
| 02/17/2005 | WO2005014559A1 Amide derivatives |
| 02/17/2005 | WO2005014558A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | WO2005014554A1 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |
| 02/17/2005 | WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/17/2005 | WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 02/17/2005 | WO2005014539A2 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | WO2005014517A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/17/2005 | WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2005013909A2 Novel cathepsin k inhibitors |
| 02/17/2005 | WO2005013907A2 Pyrrolo[1,2-b]pyridazine derivatives |
| 02/17/2005 | WO2004110993A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/17/2005 | WO2004110344A3 New azetidine compounds |
| 02/17/2005 | WO2004108068A3 4-[4-(4-morpholino)anilino]pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 02/17/2005 | WO2004094386A8 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004084813A3 Chemical compounds |
| 02/17/2005 | WO2004078114A3 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 02/17/2005 | WO2004069790A3 Crystalline modifications of triazinylaminostilbenes |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | WO2003097059A8 Polymorphic forms of phenyl oxazolidinone derivatives |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038107 Substituted 2-phenyl benzofurans as estrogenic agents |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038092 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species; side effect reductions |
| 02/17/2005 | US20050038091 Novel oxazoles, their manufacture and use as pharmaceutical agents |
| 02/17/2005 | US20050038090 cytotoxic agents; made by fermentation of Streptomyces sparsogenes |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038086 Epothilone derivatives and methods for making and using the same |
| 02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
| 02/17/2005 | US20050038074 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide; antiproliferative and -carcinogenic agents |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |